Gynesonics
US-based Gynesonics, Inc. develops and manufactures minimally invasive devices for uterine fibroids treatment.
Founded
2005US-based Gynesonics, Inc. develops and manufactures minimally invasive devices for uterine fibroids treatment.
Gynesonics, Inc., founded in Redwood City, USA, is dedicated to advancing women's health through innovative medical technologies. The company's core mission is to improve the quality of life for women suffering from uterine fibroids by providing minimally invasive therapeutic solutions. Gynesonics' flagship product, the Sonata System, offers a transcervical fibroid ablation procedure that is designed to be a safer and more effective alternative to traditional surgical methods. The company serves a global market, focusing on providing advanced healthcare solutions to women worldwide.
Notable figures associated with Gynesonics include its experienced management team and board of directors, who bring extensive expertise in medical technology and healthcare innovation. The company has attracted significant investment from leading venture capital firms, underscoring confidence in its mission and technology. Key achievements include the successful development and commercialization of the Sonata System, which has been well-received in the medical community for its efficacy and patient safety. Gynesonics continues to make a substantial impact on women's health by offering cutting-edge solutions that address unmet medical needs.
Companies similar to Gynesonics include Minerva Surgical, Mirabilis Medica, Femasys and Pharmasonics.
Gynesonics was founded in 2005.
Gynesonics' headquarters is located in Redwood City, CA, US.
Gynesonics' most recent funding round was for $42.5M (USD) in October 2023.
As of Oct 25, 2023, Gynesonics has raised a total of $401.8M (USD).
Gynesonics has 139 employees as of Feb 5, 2024.
femasys.com
